Tuesday, 25 Feb 2020

Biologic/Novel Rx

Datesort ascending Type Title Save
31 Jan 2019 Social The rheumatoid arthritis drug Xeljanz saw revenues jump 33% for the year, with total revenues coming in at $1.8 billion in 2018 https://t.co/E7KHJSgkjF
25 Jan 2019 News RheumNow Podcast – TNFs and the Inflammasome (1.25.19)
21 Jan 2019 News Smoking Doesn't Influence Rituximab Responses in Rheumatoid Arthritis
16 Jan 2019 News Anakinra for Acute Crystal-Induced Arthritis
15 Jan 2019 News IL-6 Blocker Succeeds in Real-World Vasculitis
11 Jan 2019 Social “The road to hell is paved with biologic plausibility”. - Dr. Steve Nissan
07 Jan 2019 News BMS Buyout of Celgene for $74 Billion
02 Jan 2019 News Severe Cutaneous Sarcoid Treated with Tofacitinib
25 Dec 2018 Social TB Testing - Do PPD or IGRA before TNFi or biologic - If negative, start therapy - If Positive, Eval for active TB (Sxs, CXR, C/S); if neg --> LTBI Rx BEFORE biologic - If "Indeterminate", repeat or change test. If same or neg--> start biologic - Do not do annual TST or IGRA
24 Dec 2018 News Best of 2018: Unproven But Profitable Stem Cell Clinics
30 Nov 2018 Social AstraZeneca today announced the FDA has granted Orphan Drug Status for Fasenra (benralizumab) for Eosinophilic Granulomatosis with Polyangiitis (EGPA). Fasenra is also approved for severe, eosinophilic asthma https://t.co/4ChX8D5Evx
29 Nov 2018 News Kallikrein Inhibitor Lanadelumab Prevents Hereditary Angioedema Attacks
29 Nov 2018 Social UK's NHS has spent £400million on Humira for 46,000 UK patients and starting in December will replace it with biosimilars of adalimumab at a cost of £100million https://t.co/jYzHi2pxrB
28 Nov 2018 News FDA Approves Biosimilar Rituximab for NHL, not RA
25 Nov 2018 Social Clinical Trials Benchmark for Biosimilar Development is one of several educational videos available in the "Therapeutic Update: Biosimilars in Rheumatology" video series, sponsored by Sandoz, Inc. and now available on RheumNow. https://t.co/1vmnEJqOSi
20 Nov 2018 News First FDA Approved Drug for HLH
20 Nov 2018 Social There are SIX FDA approved TNF inhibitor biosimilars in the USA - 3 infliximab (Ixifi, Renflexis, Inflectra), 2 of adalimumab (Amjevita, Cyltezo) and 1 etanercept biosimilar (Erelzi). https://t.co/xxwgvVeEXy https://t.co/ALESYJf0Zi
16 Nov 2018 Social RT @AngusWorthing: Our brief year in review video on #biosimilars for @RheumNow at #ACR18: my hope is for interchangeability pathway to bec…
09 Nov 2018 Social Frankincense is derived from Boswellia plants. Boswellia serrata is an Ayurvedic purported to be anti-inflammatory; inhibits 5-lipoxygenase & possibly prostaglandins, Pilot studies in OA have shown significant pain relief and improved physical function https://t.co/OPxal73aIF
08 Nov 2018 News Should Immunoglobulins be Monitored with Rituximab Use?